Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Boer

Showing results (31-40 of 258) with videos related to

Pageof 26
Sort By:
Biomaterials|July 1, 1987
A polymeric controlled drug delivery device for peptides based on a surface desorption/diffusion mechanismG J Boer, J Kruisbrink
The Journal of Endocrinology|September 1, 1983
Serum levels of growth hormone during the stunted postnatal development of the vasopressin-deficient Brattleboro ratG J Boer, M Rieutort
The Journal of Endocrinology|May 1, 1984
Effects of continuous administration of oxytocin by an accurel device on parturition in the rat and on development and diuresis in the offspringG J Boer, J Kruisbrink
The British Journal of Dermatology|November 1, 1996
Hidradenitis suppurativa or acne inversa. A clinicopathological study of early lesionsJ Boer, E F Weltevreden
Clinical and Experimental Dermatology|September 18, 2009
Successful treatment of dissecting cellulitis with ciprofloxacinA J Onderdijk, J Boer
Brain Research Bulletin|October 10, 2002
Clinical neurotransplantation: core assessment protocol rather than sham surgery as controlGerard J Boer, Håkan Widner
The Journal of Pharmacy and Pharmacology|December 1, 1986
The use of [3H]vasopressin for in-vivo studies of controlled delivery from an Accurel/collodion device in the Brattleboro ratJ Kruisbrink, G J Boer
Clinical and Experimental Dermatology|September 15, 2009
Successful treatment of dissecting cellulitis with ciprofloxacinA J Onderdijk, J Boer
Cell Transplantation|August 29, 2017
16th Meeting of the Network of European CNS Transplantation and Restoration (NECTAR), Amsterdam, December 8-10, 2005Gerard J Boer, Tini Eikelboom
Nederlands Tijdschrift Voor Geneeskunde|March 27, 1999
[A young patient with chronic recurrent leg ulcers; hyperhomocysteinemia and heterozygote for factor V Leiden]D N Kolbach, J Boer
Pageof 26

Showing results (31-40 of 258) with videos related to

Sort By:
Pageof 26
Biomaterials|July 1, 1987
A polymeric controlled drug delivery device for peptides based on a surface desorption/diffusion mechanismG J Boer, J Kruisbrink
The Journal of Endocrinology|September 1, 1983
Serum levels of growth hormone during the stunted postnatal development of the vasopressin-deficient Brattleboro ratG J Boer, M Rieutort
The Journal of Endocrinology|May 1, 1984
Effects of continuous administration of oxytocin by an accurel device on parturition in the rat and on development and diuresis in the offspringG J Boer, J Kruisbrink
The British Journal of Dermatology|November 1, 1996
Hidradenitis suppurativa or acne inversa. A clinicopathological study of early lesionsJ Boer, E F Weltevreden
Clinical and Experimental Dermatology|September 18, 2009
Successful treatment of dissecting cellulitis with ciprofloxacinA J Onderdijk, J Boer
Brain Research Bulletin|October 10, 2002
Clinical neurotransplantation: core assessment protocol rather than sham surgery as controlGerard J Boer, Håkan Widner
The Journal of Pharmacy and Pharmacology|December 1, 1986
The use of [3H]vasopressin for in-vivo studies of controlled delivery from an Accurel/collodion device in the Brattleboro ratJ Kruisbrink, G J Boer
Clinical and Experimental Dermatology|September 15, 2009
Successful treatment of dissecting cellulitis with ciprofloxacinA J Onderdijk, J Boer
Cell Transplantation|August 29, 2017
16th Meeting of the Network of European CNS Transplantation and Restoration (NECTAR), Amsterdam, December 8-10, 2005Gerard J Boer, Tini Eikelboom
Nederlands Tijdschrift Voor Geneeskunde|March 27, 1999
[A young patient with chronic recurrent leg ulcers; hyperhomocysteinemia and heterozygote for factor V Leiden]D N Kolbach, J Boer
Pageof 26